| Dr Jesse Toor, PHARMD | |
|
1844 San Miguel Dr Ste 105, Walnut Creek, CA 94596-8601 | |
| (925) 937-6800 | |
| (925) 937-4149 |
| Full Name | Dr Jesse Toor |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1844 San Miguel Dr Ste 105, Walnut Creek, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033962766 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 76975 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jesse Toor, PHARMD 824 Westgate Dr, Vacaville, CA 95687-7722 Ph: (707) 365-7146 | Dr Jesse Toor, PHARMD 1844 San Miguel Dr Ste 105, Walnut Creek, CA 94596-8601 Ph: (925) 937-6800 |
News Archive
Apex Medical Corporation a leading player in the Respiratory Therapy and Pressure Area Care sectors, announced that it has successfully obtained an initial advisory opinion from the United States International Trade Commission (USITC) that its continuous positive airway pressure (CPAP)-complimentary mask product is free from patent claims previously asserted by its Australia-based competitor, ResMed.
Leading edge heart valve technology is helping improve patient outcomes and giving doctors greater accuracy when implanting replacement valves. Interventional cardiologists and cardiovascular surgeons at the Orlando Health Heart Institute are the first in Central Florida to use the newly approved recapturable, self-expanding CoreValve Evolut R System.
A new study led by scientists at The Scripps Research Institute reveals that a protein first discovered at TSRI in 2010 is directly responsible for sensing touch.
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
› Verified 5 days ago
Ly Ly Choy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2880 Shadelands Dr Ste 201, Walnut Creek, CA 94598 Phone: 925-979-6832 | |
Susan Ferrante, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2880 Shadelands Dr Ste 201, Walnut Creek, CA 94598 Phone: 925-979-6802 | |
Connie Liu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-6415 | |
Elizabeth Linda Farr, BPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4655 | |
Dr. Vincent Gee Lum Ko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1526 Palos Verdes Mall, Walnut Creek, CA 94597 Phone: 808-389-0086 | |
Judy Kwak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2503 |